Academic Journal
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy
Title: | Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy |
---|---|
Authors: | Tomás Pascual, Aranzazu Fernandez-Martinez, Yash Agrawal, Adam D. Pfefferle, Nuria Chic, Fara Brasó-Maristany, Blanca Gonzàlez-Farré, Laia Paré, Guillermo Villacampa, Cristina Saura, Cristina Hernando, Montserrat Muñoz, Patricia Galván, Xavier Gonzàlez-Farré, Mafalda Oliveira, Miguel Gil-Gil, Eva Ciruelos, Patricia Villagrasa, Joaquín Gavilá, Aleix Prat, Charles M. Perou |
Source: | npj Breast Cancer, Vol 10, Iss 1, Pp 1-11 (2024) |
Publisher Information: | Nature Portfolio, 2024. |
Publication Year: | 2024 |
Collection: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Subject Terms: | Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
More Details: | Abstract In this study, we performed genomic analyses of cell cycle and tumor microenvironment changes during and after ribociclib and letrozole or chemotherapy in the CORALLEEN trial. 106 women with untreated PAM50-defined Luminal B early breast cancers were randomly assigned to receive neoadjuvant ribociclib and letrozole or standard-of-care chemotherapy. Ki67 immunohistochemistry, tumor-infiltrating lymphocytes quantification, and RNA sequencing were obtained from tissue biopsies pre-treatment, on day 14 of treatment, and tumor specimens from surgical resection. Results showed that at surgery, Ki67 and the PAM50 proliferation scores were lower after ribociclib compared to chemotherapy. However, consistent reactivation of tumor cell proliferation from day 14 to surgery was only observed in the ribociclib arm. In tumors with complete cell cycle arrest (CCCA) at surgery, PAM50 proliferation scores were lower in the ribociclib arm compared to chemotherapy (p |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2374-4677 |
Relation: | https://doaj.org/toc/2374-4677 |
DOI: | 10.1038/s41523-024-00625-7 |
Access URL: | https://doaj.org/article/3f189cf1ef8a4f74a950d11ff22079b9 |
Accession Number: | edsdoj.3f189cf1ef8a4f74a950d11ff22079b9 |
Database: | Directory of Open Access Journals |
FullText | Links: – Type: other Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=46A7A39AE6F972CB1694&Show=Object Text: Availability: 0 CustomLinks: – Url: https://doaj.org/article/3f189cf1ef8a4f74a950d11ff22079b9 Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from Directory of Open Access Journals MouseOverText: View record from Directory of Open Access Journals – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=23744677&ISBN=&volume=10&issue=1&date=20240301&spage=1&pages=1-11&title=npj Breast Cancer&atitle=Cell-cycle%20inhibition%20and%20immune%20microenvironment%20in%20breast%20cancer%20treated%20with%20ribociclib%20and%20letrozole%20or%20chemotherapy&aulast=Tom%C3%A1s%20Pascual&id=DOI:10.1038/s41523-024-00625-7 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.3f189cf1ef8a4f74a950d11ff22079b9 RelevancyScore: 1020 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 1020.40380859375 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Tomás+Pascual%22">Tomás Pascual</searchLink><br /><searchLink fieldCode="AR" term="%22Aranzazu+Fernandez-Martinez%22">Aranzazu Fernandez-Martinez</searchLink><br /><searchLink fieldCode="AR" term="%22Yash+Agrawal%22">Yash Agrawal</searchLink><br /><searchLink fieldCode="AR" term="%22Adam+D%2E+Pfefferle%22">Adam D. Pfefferle</searchLink><br /><searchLink fieldCode="AR" term="%22Nuria+Chic%22">Nuria Chic</searchLink><br /><searchLink fieldCode="AR" term="%22Fara+Brasó-Maristany%22">Fara Brasó-Maristany</searchLink><br /><searchLink fieldCode="AR" term="%22Blanca+Gonzàlez-Farré%22">Blanca Gonzàlez-Farré</searchLink><br /><searchLink fieldCode="AR" term="%22Laia+Paré%22">Laia Paré</searchLink><br /><searchLink fieldCode="AR" term="%22Guillermo+Villacampa%22">Guillermo Villacampa</searchLink><br /><searchLink fieldCode="AR" term="%22Cristina+Saura%22">Cristina Saura</searchLink><br /><searchLink fieldCode="AR" term="%22Cristina+Hernando%22">Cristina Hernando</searchLink><br /><searchLink fieldCode="AR" term="%22Montserrat+Muñoz%22">Montserrat Muñoz</searchLink><br /><searchLink fieldCode="AR" term="%22Patricia+Galván%22">Patricia Galván</searchLink><br /><searchLink fieldCode="AR" term="%22Xavier+Gonzàlez-Farré%22">Xavier Gonzàlez-Farré</searchLink><br /><searchLink fieldCode="AR" term="%22Mafalda+Oliveira%22">Mafalda Oliveira</searchLink><br /><searchLink fieldCode="AR" term="%22Miguel+Gil-Gil%22">Miguel Gil-Gil</searchLink><br /><searchLink fieldCode="AR" term="%22Eva+Ciruelos%22">Eva Ciruelos</searchLink><br /><searchLink fieldCode="AR" term="%22Patricia+Villagrasa%22">Patricia Villagrasa</searchLink><br /><searchLink fieldCode="AR" term="%22Joaquín+Gavilá%22">Joaquín Gavilá</searchLink><br /><searchLink fieldCode="AR" term="%22Aleix+Prat%22">Aleix Prat</searchLink><br /><searchLink fieldCode="AR" term="%22Charles+M%2E+Perou%22">Charles M. Perou</searchLink> – Name: TitleSource Label: Source Group: Src Data: npj Breast Cancer, Vol 10, Iss 1, Pp 1-11 (2024) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Nature Portfolio, 2024. – Name: DatePubCY Label: Publication Year Group: Date Data: 2024 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Neoplasms%2E+Tumors%2E+Oncology%2E+Including+cancer+and+carcinogens%22">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</searchLink><br /><searchLink fieldCode="DE" term="%22RC254-282%22">RC254-282</searchLink> – Name: Abstract Label: Description Group: Ab Data: Abstract In this study, we performed genomic analyses of cell cycle and tumor microenvironment changes during and after ribociclib and letrozole or chemotherapy in the CORALLEEN trial. 106 women with untreated PAM50-defined Luminal B early breast cancers were randomly assigned to receive neoadjuvant ribociclib and letrozole or standard-of-care chemotherapy. Ki67 immunohistochemistry, tumor-infiltrating lymphocytes quantification, and RNA sequencing were obtained from tissue biopsies pre-treatment, on day 14 of treatment, and tumor specimens from surgical resection. Results showed that at surgery, Ki67 and the PAM50 proliferation scores were lower after ribociclib compared to chemotherapy. However, consistent reactivation of tumor cell proliferation from day 14 to surgery was only observed in the ribociclib arm. In tumors with complete cell cycle arrest (CCCA) at surgery, PAM50 proliferation scores were lower in the ribociclib arm compared to chemotherapy (p – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 2374-4677 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://doaj.org/toc/2374-4677 – Name: DOI Label: DOI Group: ID Data: 10.1038/s41523-024-00625-7 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/3f189cf1ef8a4f74a950d11ff22079b9" linkWindow="_blank">https://doaj.org/article/3f189cf1ef8a4f74a950d11ff22079b9</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.3f189cf1ef8a4f74a950d11ff22079b9 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.3f189cf1ef8a4f74a950d11ff22079b9 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41523-024-00625-7 Languages: – Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1 Subjects: – SubjectFull: Neoplasms. Tumors. Oncology. Including cancer and carcinogens Type: general – SubjectFull: RC254-282 Type: general Titles: – TitleFull: Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tomás Pascual – PersonEntity: Name: NameFull: Aranzazu Fernandez-Martinez – PersonEntity: Name: NameFull: Yash Agrawal – PersonEntity: Name: NameFull: Adam D. Pfefferle – PersonEntity: Name: NameFull: Nuria Chic – PersonEntity: Name: NameFull: Fara Brasó-Maristany – PersonEntity: Name: NameFull: Blanca Gonzàlez-Farré – PersonEntity: Name: NameFull: Laia Paré – PersonEntity: Name: NameFull: Guillermo Villacampa – PersonEntity: Name: NameFull: Cristina Saura – PersonEntity: Name: NameFull: Cristina Hernando – PersonEntity: Name: NameFull: Montserrat Muñoz – PersonEntity: Name: NameFull: Patricia Galván – PersonEntity: Name: NameFull: Xavier Gonzàlez-Farré – PersonEntity: Name: NameFull: Mafalda Oliveira – PersonEntity: Name: NameFull: Miguel Gil-Gil – PersonEntity: Name: NameFull: Eva Ciruelos – PersonEntity: Name: NameFull: Patricia Villagrasa – PersonEntity: Name: NameFull: Joaquín Gavilá – PersonEntity: Name: NameFull: Aleix Prat – PersonEntity: Name: NameFull: Charles M. Perou IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 23744677 Numbering: – Type: volume Value: 10 – Type: issue Value: 1 Titles: – TitleFull: npj Breast Cancer Type: main |
ResultId | 1 |